{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:52:42Z","timestamp":1785275562241,"version":"3.55.0"},"reference-count":36,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tsinghua University Education Foundation, Sepsis Prevention Program","award":["202002"],"award-info":[{"award-number":["202002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>(1) Background: Both sepsis acute lung injury (SALI) and non-small-cell lung cancer (NSCLC) are life-threatening diseases caused by immune response disorders and inflammation, but the underlining linking mechanisms are still not clear. This study aimed to detect the shared gene signature and potential molecular process between SALI and NSCLC. (2) Methods: RNA sequences and patient information on sepsis and NSCLC were acquired from the Gene Expression Omnibus (GEO) database. Weighted gene co-expression network analysis (WGCNA) was used to build a co-expression network associated with sepsis and NSCLC. Protein\u2013protein interaction (PPI) analysis of shared genes was intuitively performed by the Search Tool for the Retrieval of Interacting Genes\/Proteins (STRING) database. The involvement of EZH2 in the tumor immune microenvironment (TIME) and sepsis immune microenvironment (IME) was assessed by R software. Western blot, flow cytometry, and other in vitro assays were performed to further confirm the function and mechanism of EZH2 in NSCLC and SALI. (3) Results: WGCNA recognized three major modules for sepsis and two major modules for NSCLC, and there were seven shared genes identified for the two diseases. Additionally, the hub gene EZH2 was screened out. It was shown that EZH2 was closely related to the IME in the two diseases. In the validation assay, our data showed that EZH2 was expressed at a higher level in peripheral blood mononuclear cells (PBMCs) of septic patients than those of healthy donors (HDs), and EZH2 was also expressed at a higher level in lipopolysaccharide (LPS)-induced PBMCs and non-small cell lung cancer (A549) cells. EZH2 inhibitor (GSK343) downregulated the proliferation ability of A549 cells in a concentration-dependent manner, parallel with the decreased expression level of PD-L1. Similarly, GSK343 inhibited PD-L1 protein expression and downregulated the level of proinflammatory factors in LPS-induced PBMCs. In the co-culture system of PBMCs and human type II alveolar epithelial cells (ATIIs), the addition of GSK343 to PBMCs significantly downregulated the apoptosis of LPS-induced ATIIs. (4) Conclusions: This study illustrated that EZH2 inhibition could ameliorate A549 cell proliferation and LPS-induced ATII apoptosis in parallel with downregulation of PD-L1 protein expression, which provided new insights into molecular signaling networks involved in the pathogenetics of SALI and NSCLC.<\/jats:p>","DOI":"10.3390\/cells11243958","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T02:17:57Z","timestamp":1670465877000},"page":"3958","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Inhibition of EZH2 Ameliorates Sepsis Acute Lung Injury (SALI) and Non-Small-Cell Lung Cancer (NSCLC) Proliferation through the PD-L1 Pathway"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6967-3754","authenticated-orcid":false,"given":"Ziyi","family":"Wang","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Tsinghua University, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Tsinghua University, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Tsinghua University, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Liao","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Tsinghua University, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chai","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Tsinghua University, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Tsinghua University, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Tsinghua University, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41419-018-0538-5","article-title":"Neutrophil extracellular traps promote macrophage pyroptosis in sepsis","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"677902","DOI":"10.3389\/fcimb.2021.677902","article-title":"Tissue Factor-Enriched Neutrophil Extracellular Traps Promote Immunothrombosis and Disease Progression in Sepsis-Induced Lung Injury","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"ref_3","first-page":"518","article-title":"Consensus of Chinese experts on early prevention and blocking of sepsis","volume":"32","author":"Wang","year":"2020","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: A heterogeneous set of diseases","volume":"14","author":"Chen","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","article-title":"The lung microenvironment: An important regulator of tumour growth and metastasis","volume":"19","author":"Altorki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","first-page":"217","article-title":"Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2020 Version)","volume":"24","author":"Zhou","year":"2021","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"852536","DOI":"10.3389\/fphar.2022.852536","article-title":"Construction of Severe Eosinophilic Asthma Related Competing Endogenous RNA Network by Weighted Gene Co-Expression Network Analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"756235","DOI":"10.3389\/fgene.2021.756235","article-title":"Weighted Gene Co-Expression Network Analysis and Treatment Strategies of Tumor Recurrence-Associated Hub Genes in Lung Adenocarcinoma","volume":"12","author":"Shen","year":"2021","journal-title":"Front. Gene"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"652354","DOI":"10.3389\/fonc.2021.652354","article-title":"Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJMclde1815472","article-title":"Sepsis Guidelines","volume":"380","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_11","unstructured":"Chinese Society of Critical Care Medicine, and Chinese Medical Association (2006). Guidelines for management of acute lung injury\/acute respiratory distress syndrome: An evidence-based update by the Chinese Society of Critical Care Medicine (2006). Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 18, 706\u2013710."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-020-00937-8","article-title":"EZH2: A novel target for cancer treatment","volume":"13","author":"Duan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s40425-019-0784-9","article-title":"EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma","volume":"7","author":"Xiao","year":"2019","journal-title":"J. Immun. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41419-020-2409-0","article-title":"Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression","volume":"11","author":"Zang","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1073\/pnas.1308953111","article-title":"EZH2 expands breast stem cells through activation of NOTCH1 signaling","volume":"111","author":"Gonzalez","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","first-page":"187","article-title":"Effects of histone methyltransferase inhibitor on the polarization of peritoneal macrophages in septic mice","volume":"31","author":"Zhang","year":"2019","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"111836","DOI":"10.1016\/j.biopha.2021.111836","article-title":"VitA or VitD ameliorates bronchopulmonary dysplasia by regulating the balance between M1 and M2 macrophages","volume":"141","author":"Zhen","year":"2021","journal-title":"Biomed. Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"680512","DOI":"10.3389\/fphar.2021.680512","article-title":"Ligustrazine Alleviate Acute Lung Injury Through Suppressing Pyroptosis and Apoptosis of Alveolar Macrophages","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_19","first-page":"357","article-title":"Effects and molecular mechanism of histone methyltransferase enhancer of zeste homolog 2 on regulating sepsis-induced T cell dysfunction","volume":"34","author":"Li","year":"2022","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3892\/etm.2021.9854","article-title":"EZH2 inhibitor GSK343 inhibits sepsis-induced intestinal disorders","volume":"21","author":"Yue","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000517407","article-title":"KDM6A Lysine Demethylase Directs Epigenetic Polarity of MDSCs during Murine Sepsis","volume":"14","author":"Bah","year":"2022","journal-title":"J. Innate. Immun."},{"key":"ref_22","first-page":"105899","article-title":"Novel pharmacological inhibition of EZH2 attenuates septic shock by altering innate inflammatory responses to sepsis","volume":"76","author":"Zhang","year":"2019","journal-title":"Int. Immun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3892\/ijmm.2017.2920","article-title":"Ulinastatin protects against lipopolysaccharide-induced cardiac microvascular endothelial cell dysfunction via downregulation of lncRNA MALAT1 and EZH2 in sepsis","volume":"39","author":"Yu","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Nova, Z., Skovierova, H., and Calkovska, A. (2019). Alveolar-Capillary Membrane-Related Pulmonary Cells as a Target in Endotoxin-Induced Acute Lung Injury. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040831"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3892\/mmr.2020.11109","article-title":"Tim3 regulates the ability of macrophages to counter lipopolysaccharideinduced pulmonary epithelial barrier dysfunction via the PI3K\/Akt pathway in epithelial cells","volume":"22","author":"Zhang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Arneth, B. (2019). Tumor Microenvironment. Medicina, 56.","DOI":"10.3390\/medicina56010015"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: Profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1158\/2159-8290.CD-20-1815","article-title":"Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy","volume":"11","author":"Pelly","year":"2021","journal-title":"Cancer Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1515\/hsz-2019-0436","article-title":"EZH2 function in immune cell development","volume":"401","author":"Nutt","year":"2020","journal-title":"Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2217\/epi-2020-0186","article-title":"EZH2 inhibition: A promising strategy to prevent cancer immune editing","volume":"12","author":"Kang","year":"2020","journal-title":"Epigenomics"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12974-017-0993-4","article-title":"EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment","volume":"14","author":"Yin","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e2102718118","DOI":"10.1073\/pnas.2102718118","article-title":"EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner","volume":"118","author":"Bugide","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3060480","DOI":"10.1155\/2021\/3060480","article-title":"EZH2 Might Affect Macrophage Chemotaxis and Anti-Inflammatory Factors by Regulating CCL2 in Dental Pulp Inflammation","volume":"2021","author":"Hu","year":"2021","journal-title":"Stem. Cells Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1182\/blood-2017-08-804344","article-title":"Mechanisms of resistance to EZH2 inhibitors in diffuse large B-cell lymphomas","volume":"131","author":"Bisserier","year":"2018","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.apsb.2019.09.006","article-title":"Epigenetic strategies synergize with PD-L1\/PD-1 targeted cancer immunotherapies to enhance antitumor responses","volume":"10","author":"Chen","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.2020009417","article-title":"Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis","volume":"138","author":"Wang","year":"2021","journal-title":"Blood"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/24\/3958\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:35:54Z","timestamp":1760146554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/24\/3958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":36,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["cells11243958"],"URL":"https:\/\/doi.org\/10.3390\/cells11243958","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]}}}